Marijuana Stocks: A Clinical Stage Company Presents Growth Opportunities
GTThe talent that helped build companies like Pfizer, Sanofi, Mylan and a number of other clinical and pre-clinical biotech companies is now part of the leadership team at a company that has a pipeline of novel drug therapies and could be at a major tipping point with potentially big opportunity ahead.
Click Here To Read More
Pure Play Cannabis Stocks Lead the Market
The cannabis industry has been full of a large amount of opportunity over the course of the past few months to a year or so, but new legislation in the space and the changing public perception of cannabis have all led to an increased amount of potential for growth in the market. A large amount of the growth in the space has been due to companies that purely play in the cannabis side of the industry and not the ancillary services for the market.
Click Here For More
What’s Next for the Cannabis Industry?
The cannabis industry has managed to remain extremely successful over the course of the past year or so, but new updates to legislation and the changing public perception of cannabis have all meant that investors are looking for the next thing in the marijuana space. Innovation seems to be at the core of the market, and as more companies continue to go public, it seems as though this is becoming the norm throughout the business. Here are a few companies that are working to change the game when it comes to cannabis.
Click Here For Full Release
Disclaimer: Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and GT Biopharma, Midam has been paid $200,000 from the company and ZERO shares of GT Biopharma Inc. for a duration beginning July 16, 2018 and ending August 16, 2018. Midam Ventures has been paid an additional $200k by GT Biopharma and has extended its marketing period through Sept 16, 2018. We may buy or sell additional shares of (GTBP) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
